Sae K. Joo

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Clonal hematopoiesis of indeterminate potential and metabolic dysfunction-associated steatotic liver disease: Korean biopsy cohort.

Clonal hematopoiesis of indeterminate potential and metabolic dysfunction-associated steatotic liver disease: Korean biopsy cohort.

Journal: Hepatology international

Published: April 21, 2026

Ursodeoxycholic acid and long COVID in steatotic liver disease: a nationwide cohort study.

Ursodeoxycholic acid and long COVID in steatotic liver disease: a nationwide cohort study.

Journal: Clinical and molecular hepatology

Published: March 05, 2026

Risk Prediction of Early-Onset Hepatocellular Carcinoma: Derivation and Validation in a Nationwide Young Adult Cohort.

Risk Prediction of Early-Onset Hepatocellular Carcinoma: Derivation and Validation in a Nationwide Young Adult Cohort.

Journal: Alimentary pharmacology & therapeutics

Published: January 13, 2026

Physical activity and health-related quality of life in Korean postmenopausal women with and without chronic diseases: a population-based study using the KNHANES 2016-2020 database.

Physical activity and health-related quality of life in Korean postmenopausal women with and without chronic diseases: a population-based study using the KNHANES 2016-2020 database.

Journal: Menopause (New York, N.Y.)

Published: November 12, 2025

Outcomes of oral antidiabetic drugs in metabolic dysfunction-associated steatotic liver disease: a nationwide target trial emulation study.

Outcomes of oral antidiabetic drugs in metabolic dysfunction-associated steatotic liver disease: a nationwide target trial emulation study.

Journal: Clinical and molecular hepatology

Published: September 05, 2025

Outcomes of Oral Antidiabetic Drugs in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Target Trial Emulation Study.

Outcomes of Oral Antidiabetic Drugs in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Target Trial Emulation Study.

Journal: Clinical and molecular hepatology

Published: September 05, 2025

Metabolomic profiling reveals early biomarkers of gestational diabetes mellitus and associated hepatic steatosis.

Metabolomic profiling reveals early biomarkers of gestational diabetes mellitus and associated hepatic steatosis.

Journal: Cardiovascular diabetology

Published: December 24, 2024

Young Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease Have an Increased Risk of Early-Onset Cancer: A Nationwide Cohort Study Differentiating the Risk of 23 Site-Specific Cancers.

Young Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease Have an Increased Risk of Early-Onset Cancer: A Nationwide Cohort Study Differentiating the Risk of 23 Site-Specific Cancers.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 21, 2024

How to Achieve Diversity, Equity, and Inclusion in The Korean Society of Gastroenterology?

How to Achieve Diversity, Equity, and Inclusion in The Korean Society of Gastroenterology?

Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

Published: August 31, 2024

Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Combi-Elastography versus Transient Elastography for Assessing the Histological Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Gut and liver

Published: April 30, 2024

Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review.

Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review.

Journal: Ewha medical journal

Published: March 20, 2024

Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease.

Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease.

Journal: JAMA internal medicine

Published: February 12, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026